17: Efficacy and safety of oral VT-11611 in a randomized phase 2a study in patients with acute vulvovaginal candidiasis: six-month follow-up

Journal article

Open access

Peer reviewed

S. Brand, T. Degenhardt, P. Nyirjesy, M. Augenbraun and R. Schotzinger

American journal of obstetrics and gynecology, v 213(6), pp 890-890

Dec 2015

Files and links (1)

url

https://doi.org/10.1152/ajpheart.00560.2011View

Published, Version of Record (VoR)Open Access (License Unspecified), Open

6 Record Views

Title: 17: Efficacy and safety of oral VT-11611 in a randomized phase 2a study in patients with acute vulvovaginal candidiasis: six-month follow-up
Creators: S. Brand - Viamet Pharmaceuticals (United States)
T. Degenhardt - Viamet Pharmaceuticals (United States)
P. Nyirjesy - Drexel University
M. Augenbraun - SUNY Downstate Health Sciences University
R. Schotzinger - Viamet Pharmaceuticals (United States)
Publication Details: American journal of obstetrics and gynecology, v 213(6), pp 890-890
Publisher: Elsevier
Resource Type: Journal article
Language: English
Web of Science ID: WOS:000365764900059
Other Identifier: 991019350586404721

Data related to this publication, from InCites Benchmarking & Analytics tool: